Publications

• FTC Issues Final Noncompete Rule
  24 April 2024
  Jyotin Hamid
  ,
  Ted Hassi
  ,
  Simone S. Hicks
  ,
  Meir D. Katz
  ,
  Jonathan F. Lewis
  ,
  Franklin L. Mitchell
  ,
  John (Jay) Neukom
  ,
  Michael Schaper
  ,
  J. Michael Snypes, Jr.
  ,
  Alison E. Buckley-Serfass
  ,
  Tricia Bozyk Sherno
• Private Equity Report: 2024 Outlook
  February 2024
  Christopher Anthony
  ,
  Katherine Ashton
  ,
  Andrew L. Bab
  ,
  Paul S. Bird
  ,
  Dominic Blaxill
  ,
  Ezra Borut
  ,
  Geoffrey P. Burgess
  ,
  Andrew J. Ceresney
  ,
  Charu A. Chandrasekhar
  ,
  Jennifer L. Chu
  ,
  Luke P. Eldridge
  ,
  Luke Dembosky
  ,
  E. Drew Dutton
  ,
  Jane Engelhardt
  ,
  Avi Gesser
  ,
  Andrew J. Gershon
  ,
  Nia I. Goodman
  ,
  David Grosgold
  ,
  Jyotin Hamid
  ,
  Ted Hassi
  ,
  Morgan J. Hayes
  ,
  Peter J. Irwin
  ,
  Eric T. Juergens
  ,
  Robert B. Kaplan
  ,
  M. Natasha Labovitz
  ,
  Jonathan F. Lewis
  ,
  Sidney P. Levinson
  ,
  Andrew M. Levine
  ,
  Erez Liebermann
  ,
  Timothy McIver
  ,
  Maura Kathleen Monaghan
  ,
  Edwin Northover
  ,
  Brett M. Novick
  ,
  Marc Ponchione
  ,
  Ryan T. Rafferty
  ,
  Natalie L. Reid
  ,
  Julie M. Riewe
  ,
  Kevin Rinker
  ,
  Samantha J. Rowe
  ,
  Paul D. Rubin
  ,
  Michael Schaper
  ,
  Kevin M. Schmidt
  ,
  Scott B. Selinger
  ,
  Aly Love Simons
  ,
  Thomas Smith
  ,
  Kristin A. Snyder
  ,
  Steven J. Slutzky
  ,
  Ramya S. Tiller
  ,
  Patricia Volhard
  ,
  Erica S. Weisgerber
  ,
  Kyra K. Bromley
  ,
  Alison E. Buckley-Serfass
  ,
  Jennifer R. Cestaro
  ,
  Stuart Hammer
  ,
  Jin-Hyuk Jang
  ,
  Wen-Wei Lai
  ,
  Michael P. McGuigan
  ,
  Sheena Paul
  ,
  Melissa Runsten
  ,
  Tricia Bozyk Sherno
  ,
  Ulysses Smith
  ,
  Sergio Torres
  ,
  Elie J. Worenklein
  ,
  Adam Aukland-Peck
  ,
  Josephine Chen
  ,
  Perpétua B. Chéry
  ,
  Paul Eastham
  ,
  Isabelle Glimcher
  ,
  Yiran Ji
  ,
  Maryam Kanna
  ,
  Leah Martin
  ,
  Sophie Michalski
  ,
  Diana Moise
  ,
  David J. Swiedler
  ,
  Perri M. Weinstein
  ,
  Nathan R. Hogan
• New Government Shutdown Plan—No New HSRs
  6 February 2024
  Ted Hassi
  ,
  Michael Schaper
  ,
  Erica S. Weisgerber
  ,
  Kyra K. Bromley
  ,
  Leah Martin
• FTC Announces Increases to HSR Act Thresholds and Filing Fees, and Clayton Act Section 8 Thresholds
  24 January 2024
  Ted Hassi
  ,
  Michael Schaper
  ,
  Erica S. Weisgerber
  ,
  Kyra K. Bromley
  ,
  Leah Martin
• Top 10 Healthcare and Life Sciences Issues to Watch in 2024
  4 January 2024
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Ted Hassi
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Michael Schaper
  ,
  Erica S. Weisgerber
  ,
  Kim T. Le
  ,
  Melissa Runsten
  ,
  Jacob W. Stahl
  ,
  Adam Aukland-Peck
  ,
  Ilya Balabanovsky
  ,
  Michael L. Cederblom
  ,
  Margaret Howard
  ,
  Chaim Lapp
  ,
  Hannah R. Levine
  ,
  Zoe Jacoby
  ,
  Kaitlyn McGill
• Ending 2023 with a Bang: U.S. Antitrust Agencies Issue Tough New Merger Guidelines
  20 December 2023
  Ted Hassi
  ,
  Michael Schaper
  ,
  Erica S. Weisgerber
  ,
  Chaim Lapp
  ,
  Leah Martin
• Private Equity Report Fall 2023, Vol 23, No 3
  November 2023
  Dominic Blaxill
  ,
  Michael Bolotin
  ,
  Geoffrey P. Burgess
  ,
  Charu A. Chandrasekhar
  ,
  Jennifer L. Chu
  ,
  Matthew Dickman
  ,
  Avi Gesser
  ,
  Gregory V. Gooding
  ,
  Morgan J. Hayes
  ,
  Sally Bergmann Hardesty
  ,
  Eric T. Juergens
  ,
  Franklin L. Mitchell
  ,
  Brett M. Novick
  ,
  Benjamin R. Pedersen
  ,
  William D. Regner
  ,
  Edward M. Rishty
  ,
  Michael Schaper
  ,
  Kevin M. Schmidt
  ,
  Kristin A. Snyder
  ,
  Katherine Durnan Taylor
  ,
  Ramya S. Tiller
  ,
  Robert T. Dura
  ,
  Caitlin Gibson
  ,
  Stuart Hammer
  ,
  Matt Kelly
  ,
  Sarah Wolf
  ,
  Victoria G. J. Brown
  ,
  Michelle Huang
  ,
  Matthew Stromecki
  ,
  Adam Silverwood
  ,
  Edoardo Troina
• Ready, Set, Sell: 10 Things to Consider Before Starting a Sale Process
  November 2023
  Dominic Blaxill
  ,
  Michael Bolotin
  ,
  Franklin L. Mitchell
  ,
  Brett M. Novick
  ,
  Michael Schaper
  ,
  Kevin M. Schmidt
  ,
  Katherine Durnan Taylor
  ,
  Robert T. Dura
  ,
  Caitlin Gibson
  ,
  Stuart Hammer
• A Whole New World? U.S. Antitrust Agencies Propose Tough New Merger Guidelines
  20 July 2023
  Ted Hassi
  ,
  Michael Schaper
  ,
  Erica S. Weisgerber
  ,
  Leah Martin
• FTC Proposes Sweeping Changes to HSR Rules and Filing Notification Requirements
  29 June 2023
  Ted Hassi
  ,
  Timothy McIver
  ,
  Michael Schaper
  ,
  Erica S. Weisgerber
  ,
  Kyra K. Bromley
  ,
  Anne-Mette Heemsoth
• CLS Blue Sky Blog: Debevoise & Plimpton Discusses ESG and Antitrust
  8 March 2023
  CLS Blue Sky Blog
  Ted Hassi
  ,
  Erica S. Weisgerber
  ,
  Timothy McIver
  ,
  Michael Schaper
  ,
  Ulysses Smith
• ESG and Antitrust: More Focus but No Consensus - Recent Developments, Pitfalls and Mitigating Risk
  3 March 2023
  Ted Hassi
  ,
  Timothy McIver
  ,
  Michael Schaper
  ,
  Erica S. Weisgerber
  ,
  Ulysses Smith
• FTC Announces Increases to HSR Act, Clayton Act Section 8 Thresholds, and Significant Increases in HSR Filing Fees for Largest Transactions
  26 January 2023
  Ted Hassi
  ,
  Michael Schaper
  ,
  Erica S. Weisgerber
  ,
  Kyra K. Bromley
  ,
  Leah Martin
• Reinvigorated Antitrust Enforcement of Interlocking Directorate Violations
  January 2023
  Ted Hassi
  ,
  Michael Schaper
  ,
  Erica S. Weisgerber
  ,
  Chaim Lapp
• Top 15 Healthcare and Life Sciences Issues to Watch in 2023
  9 January 2023
  Andrew L. Bab
  ,
  Jennifer L. Chu
  ,
  Mark P. Goodman
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Paul D. Rubin
  ,
  Michael Schaper
  ,
  Erica S. Weisgerber
  ,
  Kim T. Le
  ,
  Jacob W. Stahl
  ,
  Elie J. Worenklein
  ,
  Samuel J. Allaman
  ,
  Adam Aukland-Peck
  ,
  Hannah R. Levine
  ,
  Melissa Runsten
  ,
  Adam C. Saunders
  ,
  Adrian St. Francis
  ,
  Emily G. Dennan
  ,
  Michael L. Cederblom
  ,
  Micah A. Rubin
• Congress Enacts Changes to HSR Act, Significantly Increasing Filing Fees for Larger Transactions and Introducing New Foreign Subsidy Disclosure Requirements
  5 January 2023
  Michael Schaper
  ,
  Kyra K. Bromley
• FTC Sharpens Focus on Private Equity
  17 June 2022
  Andrew L. Bab
  ,
  Mark P. Goodman
  ,
  Ted Hassi
  ,
  Maura Kathleen Monaghan
  ,
  Kevin Rinker
  ,
  Michael Schaper
  ,
  Erica S. Weisgerber
  ,
  Kim T. Le
  ,
  Leah Martin
  ,
  Adam C. Saunders
• FTC Announces Increases to HSR Act and Clayton Act Section 8 Thresholds
  27 January 2022
  Ted Hassi
  ,
  Michael Schaper
  ,
  Erica S. Weisgerber
  ,
  Kyra K. Bromley
  ,
  Leah Martin
• Private Equity Report Fall 2021, Vol 21, No 3
  November 2021
  Ted Hassi
  ,
  Timothy McIver
  ,
  Michael Schaper
  ,
  Erica S. Weisgerber
  ,
  Anne-Mette Heemsoth
  ,
  Gregory V. Gooding
  ,
  Uri Herzberg
  ,
  Kevin M. Schmidt
  ,
  Katherine Durnan Taylor
  ,
  Shannon Rose Selden
  ,
  Zachary H. Saltzman
  ,
  David J. Hotelling
  ,
  Natascha Born
  ,
  Jonathan Adler
  ,
  Geoffrey Kittredge
  ,
  Ina C. Popova
  ,
  Patrick Taylor
  ,
  Cameron Sim
  ,
  Benjamin Teo
  ,
  Lillian Wong
• Buyer Beware: The FTC’s Revived and Expanded Prior Approval Policy
  8 November 2021
  Ted Hassi
  ,
  Michael Schaper
  ,
  Kevin M. Schmidt
  ,
  Erica S. Weisgerber
  ,
  Leah Martin
• President Biden Issues Sweeping Executive Order to Strengthen Antitrust Regulation and Expand Enforcement
  14 July 2021
  Ted Hassi
  ,
  Michael Schaper
  ,
  Erica S. Weisgerber
  ,
  Leah Martin
  ,
  Adam C. Saunders
• Flurry of New FTC Rules and Policies Signals Era of Aggressive Enforcement Despite Recent Supreme Court Defeat
  13 July 2021
  Ted Hassi
  ,
  Paul D. Rubin
  ,
  Michael Schaper
  ,
  Leah Martin
  ,
  Melissa Runsten
• Proposed Legislation Would Significantly Alter Antitrust Merger Standards, Particularly for Big Tech Companies
  11 February 2021
  Ted Hassi
  ,
  Michael Schaper
  ,
  Erica S. Weisgerber
• FTC Announces Decreases to HSR Act and Clayton Act Section 8 Thresholds
  3 February 2021
  Ted Hassi
  ,
  Michael Schaper
  ,
  Kyra K. Bromley
  ,
  Erica S. Weisgerber
  ,
  Leah Martin
• FTC and DOJ Antitrust Announce New Vertical Merger Guidelines
  8 July 2020
  Ted Hassi
  ,
  Michael Schaper
  ,
  Kyra K. Bromley
  ,
  Erica S. Weisgerber
  ,
  Leah Martin
• FTC Announces Annual Adjustments to HSR Act and Clayton Act Section 8 Thresholds
  29 January 2020
  Ted Hassi
  ,
  Michael Schaper
  ,
  Kyra K. Bromley
  ,
  Erica S. Weisgerber
  ,
  Leah Martin
• TMT Insights: What Is On The Horizon For Export Controls on “Emerging Technologies”? Industry Comments May Hold A Clue
  23 September 2019
  Jeffrey P. Cunard
  ,
  Michael Diz
  ,
  Jonathan E. Levitsky
  ,
  Jim Pastore
  ,
  Michael Schaper
• DOJ Antitrust Announces New Policies on Antitrust Compliance Programs
  15 July 2019
  Daniel M. Abuhoff
  ,
  Ted Hassi
  ,
  Gary W. Kubek
  ,
  Michael Schaper
  ,
  Bruce E. Yannett
  ,
  Erica S. Weisgerber
  ,
  Leah Martin
• TMT Insights: SEC Pares Back Required Content for Exhibit Filings: Takeaways for TMT
  23 April 2019
  Jeffrey P. Cunard
  ,
  Michael Diz
  ,
  Jonathan E. Levitsky
  ,
  Jim Pastore
  ,
  Paul M. Rodel
  ,
  Michael Schaper
• Employee “No-Poach” Agreements Draw Antitrust Attention and Debate
  15 March 2019
  Daniel M. Abuhoff
  ,
  Ted Hassi
  ,
  Gary W. Kubek
  ,
  Michael Schaper
  ,
  Erica S. Weisgerber
  ,
  Leah Martin
• FTC Announces Annual Adjustments to HSR Act and Clayton Act Section 8 Thresholds
  4 March 2019
  Daniel M. Abuhoff
  ,
  Ted Hassi
  ,
  Gary W. Kubek
  ,
  Michael Schaper
  ,
  Kyra K. Bromley
  ,
  Erica S. Weisgerber
  ,
  Leah Martin
• TMT Insights: A Skeptical D.C. Circuit Hears Oral Argument in the Government’s Appeal of the AT&T-Time Warner Merger
  21 December 2018
  Michael Diz
  ,
  Jonathan E. Levitsky
  ,
  Jim Pastore
  ,
  Michael Schaper
  ,
  Leah Martin
• TMT Insights: CFIUS Launches Pilot Program Targeted at Technology
  9 November 2018
  Michael Diz
  ,
  Jonathan E. Levitsky
  ,
  Jim Pastore
  ,
  Michael Schaper
  ,
  Jeffrey P. Cunard
• TMT Insights: Key Insights from the New York AI in Finance Summit
  18 October 2018
  Michael Diz
  ,
  Jonathan E. Levitsky
  ,
  Jim Pastore
  ,
  Michael Schaper
• TMT Insights: Derived Data: Contracting Considerations and Market Practices
  30 August 2018
  Jeffrey P. Cunard
  ,
  Michael Diz
  ,
  Henry Lebowitz
  ,
  Jonathan E. Levitsky
  ,
  Jim Pastore
  ,
  Michael Schaper
• AT&T/Time Warner Merger Clearance Paves Way for Future Transactions
  13 June 2018
  Daniel M. Abuhoff
  ,
  Michael Diz
  ,
  Gary W. Kubek
  ,
  William D. Regner
  ,
  Michael Schaper
• TMT Insights: A Checklist for Cybersecurity and Data Privacy Diligence in TMT Transactions
  30 May 2018
  Jeffrey P. Cunard
  ,
  Michael Diz
  ,
  Jonathan E. Levitsky
  ,
  Jim Pastore
  ,
  Michael Schaper
• Game Over: New York’s Highest Court Rejects Right of Publicity Claims Against Grand Theft Auto V
  2 April 2018
  David H. Bernstein
  ,
  Michael Schaper
  ,
  Jared I. Kagan
• Loyalty rebates in the EU (after Intel) and the U.S.
  12 February 2018
  ABA Distribution and Franchising Newsletter
  Michael Schaper
• FTC Emphasizes the Importance of Testing Disclosures
  30 September 2016
  David H. Bernstein
  ,
  Michael Schaper
  ,
  Megan K. Bannigan
• The FTC Draws the Line on Native Advertising
  23 March 2016
  David H. Bernstein
  ,
  Michael Schaper
  ,
  Megan K. Bannigan
• D.C. Circuit's POM Wonderful Decision Points To Reduced Substantiation Burden For Advertisers
  4 February 2015
  David H. Bernstein
  ,
  Michael Schaper
• Private Equity Sponsor Fined for Cartel Activity of Portfolio Company
  10 April 2014
  Gary W. Kubek
  ,
  Michael Schaper
  ,
  Timothy McIver
• FTC Expands Scope of Reportable Pharma Patent Licenses under the Hart-Scott-Rodino Act
  8 November 2013
  Daniel M. Abuhoff
  ,
  Kyra K. Bromley
  ,
  Gary W. Kubek
  ,
  Michael Schaper
• Strategic Thinking: Special Considerations for Private Equity Sponsors Contemplating Add-On Acquisitions
  Winter 2013
  Kevin M. Schmidt
  ,
  Michael Schaper
• Supreme Court Says ‘Reverse Payment’ Generic Drug Settlements Are Subject to Rule of Reason Antitrust Review
  18 June 2013
  Daniel M. Abuhoff
  ,
  Gary W. Kubek
  ,
  Michael Schaper
• Strategic Thinking: Special Considerations for Private Equity Sponsors Contemplating Add-On Acquisitions
  June 2013
  The M&A Lawyer
  Kevin M. Schmidt
  ,
  Michael Schaper
• The Private Equity Report
  Winter 2013
  Jonathan F. Lewis
  ,
  E. Drew Dutton
  ,
  David Innes
  ,
  Andrew M. Ostrognai
  ,
  Eric Dinallo
  ,
  Kenneth J. Berman
  ,
  Robert B. Kaplan
  ,
  Michael P. Harrell
  ,
  Jonathan R. Tuttle
  ,
  Kevin M. Schmidt
  ,
  Michael Schaper
  ,
  Peter F.G. Schuur
  ,
  Adele M. Karig
  ,
  Matthew D. Saronson
• EU Commission Ends Antitrust Proceeding After Areva and Siemens Agree to Limit Scope of Non-Compete and Confidentiality Obligations
  29 June 2012
  Dr. Thomas Schürrle
  ,
  Daniel M. Abuhoff
  ,
  Gary W. Kubek
  ,
  Michael Schaper
  ,
  Timothy McIver
• Third Circuit Approves Broad De Beers Diamond Settlement Class, But Does It Also Reopen the Door for Certification of Multistate Litigation Classes?
  22 December 2011
  Daniel M. Abuhoff
  ,
  Gary W. Kubek
  ,
  Michael Schaper
• FTC Implements Revisions to HSR Premerger Filing Requirements
  12 July 2011
  Daniel M. Abuhoff
  ,
  Gary W. Kubek
  ,
  Michael Schaper
  ,
  Kyra K. Bromley
• A Tougher Standard for Class in Antitrust Action
  9 January 2009
  Competition Law360
  Daniel M. Abuhoff
  ,
  Gary W. Kubek
  ,
  Michael Schaper
• New Decision Supports Tougher Standard for Class Certification in Antitrust Actions
  6 January 2009
  Daniel M. Abuhoff
  ,
  Gary W. Kubek
  ,
  Michael Schaper
• Getting Private Equity Deals Done in the Current Antitrust Environment
  November 2021
  Ted Hassi
  ,
  Timothy McIver
  ,
  Michael Schaper
  ,
  Kevin M. Schmidt
  ,
  Erica S. Weisgerber
  ,
  Anne-Mette Heemsoth